Abstract:Accumulating evidence has demonstrated that FHIT (fragile histidine triad) is a bona fide tumour suppressor gene in a large fraction of human tumours, including hepatocellular cancer. A virus-based delivery system has been developed to transfer the FHIT gene into many types of cancer cells to inhibit growth or even induce apoptosis. However, a protein-based replacement strategy for FHIT has not been performed in cancer cells. Here, we used HIV-TAT (transactivator of transcription)-derived peptide to transfer the purified FHIT protein into HCC (hepatocellular carcinoma) cells and determine the biological effect of this fusion protein in inducing apoptosis. Affinity chromatography was used to purify TAT peptide-fused human FHIT (TAT–FHIT) protein from BL21 Escherichia coli. Immunofluorescence staining and Western blot analysis were performed to identify the expression and internalization of TAT–FHIT in HCC cells compared with the purified FHIT protein. Our study showed that TAT–FHIT protein can translocate into cancer cells in 1 h after incubation at 37°C. Furthermore, the results of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] assay, Annexin-V staining and Western blotting demonstrated that TAT–FHIT can robustly inhibit growth and induce apoptosis of HCC cells in vitro. In addition, a mechanistic study showed that both exogenous and intrinsic apoptotic pathways were involved in TAT–FHIT-mediated apoptosis and this effect could be attenuated partially by a mitochondrial protector TAT-BH4, indicating that mitochondrion plays a critical role in TAT–FHIT-mediated pro-apoptotic effect in cancer cells. Taken together, our study suggests that TAT–FHIT is a potential pro-apoptotic molecule in HCC cells and strengthen the hypothesis of its therapeutic application against HCC.

Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.

Regulation of Dna Methylation on the Expression of the Fhit Gene Contributes to Cervical Carcinoma Cell Tumorigenesis

[Effects of Ectogenous FHIT Gene on Reversing Malignant Phenotype of Human Lung Adenocarcinoma Cells A549].

[Reduction of FHIT Gene Expression in Primary Lung Cancer: Relationship with the Proliferation and Apoptosis of Tumor Cell].

Down-Regulation of Fhit Inhibits Apoptosis of Colorectal Cancer: Mechanism and Clinical Implication

Aberrant FHIT expression is linked to bladder carcinogenesis and apoptosis.

Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene.

FHIT Promotes the Apoptosis of QBC939 by Reducing the Expression of Cyclin D1.

A study on the allelic deletion and mutation of FHIT gene in human non-small cell lung cancer

Study of mRNA Expressions of FHIT Genes in Patients with Non- small Cell Lung Cancer

HIV-TAT-fused FHIT Protein Functions As a Potential Pro-Apoptotic Molecule in Hepatocellular Carcinoma Cells.

Reduction of FHIT Gene Expression in Primary Lung Cancer

A study on transcript abnormalities of FHIT gene in human non-small cell lung cancer

[Mutation and Abnormal Expression of FHIT Gene in Hypopharyngeal Carcinoma].

Upregulation of FHIT Gene Expression in Endometrial Carcinoma by RNA Activation.

The Aberrant Methylation of Fragile Histidine Triad (FHIT) Gene and Its Significance of the Expression of FHIT Protein in Lung Cancer

Two-Hit Inactivation Of Fhit By Loss Of Heterozygosity And Hypermethylation In Breast Cancer

The Study on the Correlation Between FHIT Gene and Esophageal Carcinoma

Involvement of the Fhit Gene in the Ionizing Radiation-Activated Atr/Chk1 Pathway

Fhit and CHK1 have opposing effects on homologous recombination repair.

Effect of Fragile Histidine Triad Gene on Apoptosis of MGC-803 Gastric Cancer Cells